NGA
VIVO

Naples Global Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Naples Global Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67,447
Closed -$1.19M – 274
2016
Q4 		$1.19M Sell
67,447
-225
-0.3% -$3.95K 0.46% 72
2016
Q3 		$1.3M Buy
67,672
+11,750
+21% +$230K 0.51% 62
2016
Q2 		$1.09M Buy
55,922
+4,750
+9% +$93.2K 0.45% 84
2016
Q1 		$1.05M Sell
51,172
-1,840
-3% -$36.3K 0.44% 83
2015
Q4 		$1.09M Buy
53,012
+1,000
+2% +$19.2K 0.53% 70
2015
Q3 		$889K Buy
52,012
+1,670
+3% +$30.5K 0.46% 85
2015
Q2 		$938K Buy
50,342
+1,990
+4% +$36.9K 0.45% 89
2015
Q1 		$923K Buy
48,352
+150
+0.3% +$2.77K 0.44% 95
2014
Q4 		$793K Buy
48,202
+1,800
+4% +$30.9K 0.42% 104
2014
Q3 		$821K Buy
46,402
+3,180
+7% +$62.5K 0.48% 86
2014
Q2 		$892K Buy
43,222
+5,885
+16% +$121K 0.53% 71
2014
Q1 		$814K Buy
37,337
+6,765
+22% +$155K 0.5% 71
2013
Q4 		$811K Buy
+30,572
New +$751K 0.54% 58

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Naples Global Advisors's VIVO Position: Q1 2017 in Review

Naples Global Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 67,447 shares — an estimated $1.19M sold.

Naples Global Advisors first reported a position in VIVO in Q4 2013 and held it in 13 quarters. The position peaked at $1.3M in Q3 2016. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

  • Naples Global Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
  • Naples Global Advisors sold 67,447 Meridian Bioscience Inc shares in Q1 2017, an estimated $1.19M.
  • Naples Global Advisors first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 13 quarters.
  • Naples Global Advisors's Meridian Bioscience Inc position peaked at $1.3M in Q3 2016.
  • 165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Naples Global Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.